News Links

Quantification of the Glycemic Response to Microdoses of Subcutaneous Glucagon at Varying Insulin Levels. Glucagon in the Artificial Pancreas: Supply and Marketing Challenges. New insulin glargine 300 U/mL provides a more even activity profile and prolonged glycemic control at steady state compared with insulin glargine 100 U/mL. End stage renal disease and survival in people with diabetes: a national database linkage study. Free full text available in PDF format. Islet and Stem Cell Encapsulation for Clinical Transplantation. Lack of Evidence for a Role of Islet Autoimmunity in the Aetiology of Canine Diabetes Mellitus. In patients with type 1 diabetes simultaneous […]

Effect of Local Heating on Postprandial Blood Glucose Excursions Using the InsuPad Device: Results of an Outpatient Crossover Study. The prevalence of type 1 diabetes mellitus among 15-34-year-aged Lithuanian inhabitants during 1991-2010. Study of factors influencing susceptibility and age at onset of type 1 diabetes: A review of data from Continental Italy and Sardinia. Free full text available in HTML and PDF formats. Long-term outcomes of clinical transplantation of pancreatic islets with uncontrolled donors after cardiac death: a multicenter experience in Japan. Distinct clinical and laboratory characteristics of latent autoimmune diabetes in adults in relation to type 1 and type […]

Incidence and temporal trends of childhood type 1 diabetes between 1975 and 2012 in Navarre (Spain). Preliminary Evaluation of a New Semi-Closed-Loop Insulin Therapy System Over the Prandial Period in Adult Patients With Type 1 Diabetes: The WP6.0 Diabeloop Study. A CD40-targeted peptide controls and reverses type 1 diabetes in NOD mice.

MD-Logic Overnight Control for 6 Weeks of Home Use in Patients With Type 1 Diabetes: Randomized Crossover Trial. Maternal anxiety about a child’s diabetes risk in the TEDDY study: the potential role of life stress, postpartum depression, and risk perception. Incidence of type 1 diabetes mellitus in 0 to 14-yr-old children in Croatia – 2004 to 2012 study. Accuracy of a New Patch Pump Based on a Microelectromechanical System (MEMS) Compared to Other Commercially Available Insulin Pumps: Results of the First In Vitro and In Vivo Studies. Mode of Obstetrical Delivery and Type 1 Diabetes: A Sibling Design Study. Islet […]

Novel Insulin Delivery Profiles for Mixed Meals for Sensor-Augmented Pump and Closed-Loop Artificial Pancreas Therapy for Type 1 Diabetes Mellitus. An Increase in Serum 25-Hydroxyvitamin D Concentrations Preceded a Plateau in Type 1 Diabetes Incidence in Finnish Children. Enterovirus RNA in longitudinal blood samples and risk of islet autoimmunity in children with a high genetic risk of type 1 diabetes: the MIDIA study. GLP-1 receptor activation modulates appetite- and reward-related brain areas in humans.

Early infant feeding and risk of developing islet autoimmunity and type 1 diabetes. A plasmonic chip for biomarker discovery and diagnosis of type 1 diabetes. Autologous hematopoietic stem cell transplantation and conventional insulin therapy in the treatment of children with newly diagnosed type 1 diabetes: long term follow-up. Free full text available in HTML and PDF (via link) formats. Role of Glucagon-Like Peptide-1 Analogue Versus Amylin as an Adjuvant Therapy in Type 1 Diabetes in a Closed Loop Setting With ePID Algorithm. The risk for diabetic nephropathy is low in young adults in a 17-year follow-up of the Diabetes Incidence […]

Multicenter Closed-Loop Insulin Delivery Study Points to Challenges for Keeping Blood Glucose in a Safe Range by a Control Algorithm in Adults and Adolescents with Type 1 Diabetes from Various Sites. Low-Dose Otelixizumab Anti-CD3 Monoclonal Antibody DEFEND-1 Study: Results of the Randomized Phase III Study in Recent-Onset Human Type 1 Diabetes. Short-term effects of NPH insulin, insulin detemir and insulin glargine on the GH – IGF-I – IGFBP axis in patients with type 1 diabetes. Changes in Glucose and Fat Metabolism in Response to the Administration of a Hepato-Preferential Insulin Analog. The effect of autoimmunity on the development time of […]

Combination therapy with sitagliptin and lansoprazole in patients with recent-onset type 1 diabetes (REPAIR-T1D): 12-month results of a multicentre, randomised, placebo-controlled, phase 2 trial. Targeted immune interventions for type 1 diabetes: not as easy as it looks! Neurocognitive Functioning in Children and Adolescents at the Time of Type 1 Diabetes Diagnosis: Associations With Glycemic Control 1 Year After Diagnosis. Do children with type 1 diabetes have a relation between adiponectin level and vascular complications? Skin Fibroblasts from Patients with Type 1 Diabetes (T1D) Can Be Chemically Transdifferentiated into Insulin-Expressing Clusters: A Transgene-Free Approach. Free full text available in HTML and […]

Is Type 1 Diabetes “Going Viral”? Free full text available in PDF format. Microbial Exposure in Infancy and Subsequent Appearance of Type 1 Diabetes Mellitus�Associated Autoantibodies. See also Finnish study: Having a dog at home may prevent diabetes. Home use of closed-loop insulin delivery for overnight glucose control in adults with type 1 diabetes: a 4-week, multicentre, randomised crossover study. GAD autoantibody affinity in schoolchildren from the general population. Artificial pancreas: fuzzy logic and control of glycemia. Advanced Insulin Bolus Advisor based on Run-To-Run Control and Case-Based Reasoning. Gut microbiota, probiotics and diabetes. Free full text available in PDF format.

Outpatient Glycemic Control with a Bionic Pancreas in Type 1 Diabetes. Free full text available in HTML and PDF formats. Safety of Outpatient Closed-Loop Control: First Randomized Crossover Trials of a Wearable Artificial Pancreas. Lipohypertrophy and the Artificial Pancreas. Is This an Issue? Free full text available in PDF format. Aberrant gut microbiota composition at the onset of type 1 diabetes in young children. Associations between Bone, Fat Tissue and Metabolic Control in Children and Adolescents with Type 1 Diabetes Mellitus. Leptin reverses diabetes by suppression of the hypothalamic-pituitary-adrenal axis. Markers of endothelial dysfunction and inflammation predict progression of diabetic […]